Mesoblast

$7.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (2.63%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Mesoblast and other stocks, options, ETFs, and crypto commission-free!

About MESO

Mesoblast Limited American Depositary Shares, also called Mesoblast, is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. Read More The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Employees
83
Headquarters
Melbourne, Victoria (VIC)
Founded
2004
Market Cap
716.00M
Price-Earnings Ratio
Dividend Yield
Average Volume
112.98K
High Today
$7.59
Low Today
$7.30
Open Price
$7.30
Volume
81.21K
52 Week High
$8.78
52 Week Low
$3.35

Collections

MESO Earnings

-$0.26
-$0.18
-$0.10
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
Actual
Expected Nov 14, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.